Photophobia and drugs of ingredients of lopinavir; ritonavir - a phase IV clinical study of FDA data
Photophobia is found among people who take drugs with ingredients of lopinavir; ritonavir, especially for people who are male, 40-49 old , have been taking the drugs for 1 - 6 months. This phase IV clinical study is created by eHealthMe based on reports of 33,306 people who have side effects when taking drugs with ingredients of lopinavir; ritonavir from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Kaletra, Lopinavir; ritonavir.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
33,306 people reported to have side effects when taking drugs with ingredients of lopinavir; ritonavir.
Among them, 13 people (0.04%) have Photophobia
What is Photophobia?
Photophobia (extreme sensitivity to light) is found to be associated with 2,279 drugs and 1,681 conditions by eHealthMe.
Number of reports submitted per year:
Time on drugs with ingredients of lopinavir; ritonavir when people have Photophobia *:
- < 1 month: 14.29 %
- 1 - 6 months: 42.86 %
- 6 - 12 months: 28.57 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 14.29 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Photophobia when taking drugs with ingredients of lopinavir; ritonavir *:
- female: 7.69 %
- male: 92.31 %
Age of people who have Photophobia when taking drugs with ingredients of lopinavir; ritonavir *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 20 %
- 30-39: 20 %
- 40-49: 40 %
- 50-59: 20 %
- 60+: 0.0 %
Conditions people have *:
- Headache (pain in head): 2 people, 15.38%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.69%
- Diarrhea: 1 person, 7.69%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 7.69%
Other drugs people take *:
- Atazanavir Sulfate: 2 people, 15.38%
- Reyataz: 2 people, 15.38%
- Emtriva: 2 people, 15.38%
- Epivir: 2 people, 15.38%
- Viread: 1 person, 7.69%
- Isoniazid: 1 person, 7.69%
- Celexa: 1 person, 7.69%
- Combivir: 1 person, 7.69%
- Glivec: 1 person, 7.69%
- Ibuprofen: 1 person, 7.69%
Other side effects people have besides Photophobia *:
- Nausea And Vomiting: 8 people, 61.54%
- Headache (pain in head): 8 people, 61.54%
- Weakness: 6 people, 46.15%
- Encephalitis (inflammation of the brain): 5 people, 38.46%
- Nausea (feeling of having an urge to vomit): 5 people, 38.46%
- Fever: 4 people, 30.77%
- Strabismus (a disorder in which the two eyes do not line up in the same direction): 3 people, 23.08%
- Binocular Eye Movement Disorder: 3 people, 23.08%
- Diplopia (double vision): 3 people, 23.08%
- Muscle Rigidity (muscle stiffness): 3 people, 23.08%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drugs with ingredients of lopinavir; ritonavir, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on lopinavir; ritonavir. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Apresoline and Alkeran drug interaction - now
- Pradaxa and Hypophysitis - 4 seconds ago
- Trimethoprim and Haemoglobin Increased - 5 seconds ago
- Humalog and Blood Glucose Increased - 11 seconds ago
- Chronic Thyroiditis and Fever - 24 seconds ago
- Esomeprazole Magnesium and Rimifon drug interaction - 35 seconds ago
- Solu-Medrol and Appendicitis Perforated - 38 seconds ago
- Acute Myocardial Infarction and Urination - Excessive Volume - 39 seconds ago
- Mesalamine and Zinc Deficiency - 54 seconds ago
- Depo-Subq Provera 104 vs. Femcon Fe - 57 seconds ago